Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 21.1M 19.63M 17.85M 33.71M 2.29B 33.85M 236M 92.56M 1.17B 88.72M 86.78M 3.74B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 37.68M 35.05M 31.88M 60.19M 4.08B 60.45M 422M 165M 2.08B 158M 155M 6.68B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
17-08-04 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
17-05-15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
17-02-13 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
16-11-13 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
16-10-04 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16-05-16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
16-02-08 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
16-02-01 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
15-12-10 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
15-12-04 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
15-12-01 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
15-11-13 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
15-10-12 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 day+4.55%
1 week+4.55%
Current month+4.55%
1 month+9.52%
3 months-36.11%
6 months-68.06%
Current year-30.30%
1 week 0
Extreme 0.0023
0
1 month 0
Extreme 0.0021
0
Current year 0
Extreme 0.0011
0.01
1 year 0
Extreme 0.0011
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
+4.55%+4.55%-54.00%+91.67% 877K
+3.26%+2.70%-32.14%-50.39% 1.75B
-0.48%-0.94% - - 1.52B
+1.41%+8.66%-31.37%+141.09% 1.14B
+2.49%+3.06%-46.46%+9.44% 1.02B
+3.85%+6.19%+50.32%+39.17% 995M
-3.71%-4.95%+181.09%+782.28% 919M
+0.34%+2.81%+6.93%+53.67% 770M
+0.36%+5.41%+10.64%+176.27% 745M
+4.07%+3.94%+42.22%-33.73% 538M
Average +1.59%+2.40%+14.14%+134.39% 939.91M
Weighted average by Cap. +1.28%+2.65%+14.34%+126.21%

Financials

2015 2016
Net sales 25.48M 22.76M 21.17M 19.26M 36.36M 2.47B 36.51M 255M 99.83M 1.26B 95.69M 93.59M 4.03B 32.33M 28.87M 26.86M 24.43M 46.13M 3.13B 46.33M 323M 127M 1.6B 121M 119M 5.12B
Net income 5.49M 4.91M 4.57M 4.15M 7.84M 532M 7.87M 54.94M 21.53M 271M 20.63M 20.18M 870M 2.06M 1.84M 1.71M 1.56M 2.94M 199M 2.95M 20.61M 8.08M 102M 7.74M 7.57M 326M
Net Debt 24.8M 22.15M 20.61M 18.74M 35.39M 2.4B 35.54M 248M 97.18M 1.22B 93.15M 91.11M 3.93B 18.56M 16.58M 15.42M 14.03M 26.48M 1.8B 26.6M 186M 72.72M 916M 69.7M 68.17M 2.94B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
26-10-08 US$0.002300 +4.55% 500
  1. Stock Market
  2. Stocks
  3. AOXG Stock